Search research articles
Contact Us
Filters
Showing results (31-40 of 150) with videos related to
Page
of 15
Sort By:
Health Economics
|
September 24, 2004
Health state values for the HUI 2 descriptive system: results from a UK survey
Christopher McCabe, Katherine Stevens, Jennifer Roberts, et al.
International Journal of Technology Assessment in Health Care
|
June 21, 2007
Assessing the economic challenges posed by orphan drugs: a comment on Drummond et al
Christopher McCabe, Aki Tsuchiya, Karl Claxton, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
June 28, 2014
Sharing risk between payer and provider by leasing health technologies: an affordable and effective reimbursement strategy for innovative technologies?
Richard Edlin, Peter Hall, Klemens Wallner, et al.
British Journal of Clinical Pharmacology
|
August 19, 2010
Cost-effectiveness analysis and efficient use of the pharmaceutical budget: the key role of clinical pharmacologists
Richard Edlin, Jeff Round, Claire Hulme, et al.
Current Vascular Pharmacology
|
October 27, 2005
Endothelin and the ischaemic heart
Cherry L Wainwright, Christopher McCabe, Kathleen A Kane
Pharmacoeconomics
|
May 11, 2017
A Comparison of Four Software Programs for Implementing Decision Analytic Cost-Effectiveness Models
Chase Hollman, Mike Paulden, Petros Pechlivanoglou, et al.
Pharmacoeconomics
|
March 23, 2016
Cancer Drugs Fund 2.0: A Missed Opportunity?
Christopher McCabe, Ash Paul, Greg Fell, et al.
Pharmacoeconomics
|
November 22, 2014
Value-based reimbursement decisions for orphan drugs: a scoping review and decision framework
Mike Paulden, Tania Stafinski, Devidas Menon, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
July 2, 2022
A Conceptual Framework for Life-Cycle Health Technology Assessment
Erin Kirwin, Jeff Round, Ken Bond, et al.
Experimental & Translational Stroke Medicine
|
October 21, 2016
Therapeutic potential of the renin angiotensin system in ischaemic stroke
Mariana Moreira Coutinho Arroja, Emma Reid, Christopher McCabe
Page
of 15
Search research articles
Search
Showing results (31-40 of 150) with videos related to
Sort By:
Page
of 15
Health Economics
|
September 24, 2004
Health state values for the HUI 2 descriptive system: results from a UK survey
Christopher McCabe, Katherine Stevens, Jennifer Roberts, et al.
International Journal of Technology Assessment in Health Care
|
June 21, 2007
Assessing the economic challenges posed by orphan drugs: a comment on Drummond et al
Christopher McCabe, Aki Tsuchiya, Karl Claxton, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
June 28, 2014
Sharing risk between payer and provider by leasing health technologies: an affordable and effective reimbursement strategy for innovative technologies?
Richard Edlin, Peter Hall, Klemens Wallner, et al.
British Journal of Clinical Pharmacology
|
August 19, 2010
Cost-effectiveness analysis and efficient use of the pharmaceutical budget: the key role of clinical pharmacologists
Richard Edlin, Jeff Round, Claire Hulme, et al.
Current Vascular Pharmacology
|
October 27, 2005
Endothelin and the ischaemic heart
Cherry L Wainwright, Christopher McCabe, Kathleen A Kane
Pharmacoeconomics
|
May 11, 2017
A Comparison of Four Software Programs for Implementing Decision Analytic Cost-Effectiveness Models
Chase Hollman, Mike Paulden, Petros Pechlivanoglou, et al.
Pharmacoeconomics
|
March 23, 2016
Cancer Drugs Fund 2.0: A Missed Opportunity?
Christopher McCabe, Ash Paul, Greg Fell, et al.
Pharmacoeconomics
|
November 22, 2014
Value-based reimbursement decisions for orphan drugs: a scoping review and decision framework
Mike Paulden, Tania Stafinski, Devidas Menon, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
July 2, 2022
A Conceptual Framework for Life-Cycle Health Technology Assessment
Erin Kirwin, Jeff Round, Ken Bond, et al.
Experimental & Translational Stroke Medicine
|
October 21, 2016
Therapeutic potential of the renin angiotensin system in ischaemic stroke
Mariana Moreira Coutinho Arroja, Emma Reid, Christopher McCabe
Page
of 15